During this emergency, there may be times that prompt connection time takes a little longer. Providers are doing their best to fully staff their call centers to ensure that the phones are answered as quickly as possible.
A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.
Human beings are social creatures. This special report, featuring comments from leading experts in psychology and audiology, reviews new and important research on hearing loss, and shows why audiological care needs to renew its focus on helping patients regain their communication and social engagement activities—those things that make life meaningful and rewarding.
Biotechnology company, Eosera, announced that it is not only expanding its line of products, but also moving to a facility that is double the size of its previous location, and hiring four new team members in three different capacities.